Research ArticleArticle
Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary
John D. Pauling, Jacqueline A. Shipley, Darren J. Hart, Anita McGrogan and Neil J. McHugh
The Journal of Rheumatology June 2015, jrheum.141437; DOI: https://doi.org/10.3899/jrheum.141437
John D. Pauling
From the Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; and the Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. Supported by the Raynaud’s and Scleroderma Association as part of the Dando fellowship. J.D. Pauling, BMedSci, BMBS, MRCP, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath; J.A. Shipley, BSc, PhD; D.J. Hart, BSc, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; A. McGrogan, PhD, Department of Pharmacy and Pharmacology, University of Bath; N.J. McHugh, BMBS, FRCP, FRCPath, MD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath. Address correspondence to Dr. J.D. Pauling, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, United Kingdom. E-mail: John.Pauling@rnhrd.nhs.uk. Accepted for publication March 2, 2015.
Jacqueline A. Shipley
From the Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; and the Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. Supported by the Raynaud’s and Scleroderma Association as part of the Dando fellowship. J.D. Pauling, BMedSci, BMBS, MRCP, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath; J.A. Shipley, BSc, PhD; D.J. Hart, BSc, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; A. McGrogan, PhD, Department of Pharmacy and Pharmacology, University of Bath; N.J. McHugh, BMBS, FRCP, FRCPath, MD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath. Address correspondence to Dr. J.D. Pauling, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, United Kingdom. E-mail: John.Pauling@rnhrd.nhs.uk. Accepted for publication March 2, 2015.
Darren J. Hart
From the Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; and the Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. Supported by the Raynaud’s and Scleroderma Association as part of the Dando fellowship. J.D. Pauling, BMedSci, BMBS, MRCP, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath; J.A. Shipley, BSc, PhD; D.J. Hart, BSc, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; A. McGrogan, PhD, Department of Pharmacy and Pharmacology, University of Bath; N.J. McHugh, BMBS, FRCP, FRCPath, MD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath. Address correspondence to Dr. J.D. Pauling, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, United Kingdom. E-mail: John.Pauling@rnhrd.nhs.uk. Accepted for publication March 2, 2015.
Anita McGrogan
From the Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; and the Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. Supported by the Raynaud’s and Scleroderma Association as part of the Dando fellowship. J.D. Pauling, BMedSci, BMBS, MRCP, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath; J.A. Shipley, BSc, PhD; D.J. Hart, BSc, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; A. McGrogan, PhD, Department of Pharmacy and Pharmacology, University of Bath; N.J. McHugh, BMBS, FRCP, FRCPath, MD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath. Address correspondence to Dr. J.D. Pauling, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, United Kingdom. E-mail: John.Pauling@rnhrd.nhs.uk. Accepted for publication March 2, 2015.
Neil J. McHugh
From the Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; and the Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. Supported by the Raynaud’s and Scleroderma Association as part of the Dando fellowship. J.D. Pauling, BMedSci, BMBS, MRCP, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath; J.A. Shipley, BSc, PhD; D.J. Hart, BSc, PhD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases; A. McGrogan, PhD, Department of Pharmacy and Pharmacology, University of Bath; N.J. McHugh, BMBS, FRCP, FRCPath, MD, Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, and Department of Pharmacy and Pharmacology, University of Bath. Address correspondence to Dr. J.D. Pauling, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, BA1 1RL, United Kingdom. E-mail: John.Pauling@rnhrd.nhs.uk. Accepted for publication March 2, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary
John D. Pauling, Jacqueline A. Shipley, Darren J. Hart, Anita McGrogan, Neil J. McHugh
The Journal of Rheumatology Jun 2015, jrheum.141437; DOI: 10.3899/jrheum.141437
Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary
John D. Pauling, Jacqueline A. Shipley, Darren J. Hart, Anita McGrogan, Neil J. McHugh
The Journal of Rheumatology Jun 2015, jrheum.141437; DOI: 10.3899/jrheum.141437